WHO expert committee on leprosy ; Eighth report
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 52990814X | ||
| 003 | CHVBK | ||
| 005 | 20201001101748.0 | ||
| 008 | 181018s2012 sz 10 eng | ||
| 020 | |a 978-92-4-120968-7 | ||
| 035 | |a (IDSBB)005994063 | ||
| 035 | |a (NEBIS)011131686 | ||
| 035 | |a (OCoLC)930817393 | ||
| 040 | |a SzZuIDS BS/BE A322 |e kids | ||
| 084 | |a 44.75 |2 bcl | ||
| 245 | 0 | 0 | |a WHO expert committee on leprosy ; Eighth report |c World Health Organization |
| 246 | 1 | 3 | |a Eighth report of the WHO Expert Committee on Leprosy |
| 264 | 1 | |a Geneva |b World Health Organization |c 2012 | |
| 300 | |a 61 S. |b Ill. | ||
| 490 | 0 | |a Technical report series / World Health Organization |v no. 968 |i 968 |w (IDSBB)005953281 |9 278782957 | |
| 500 | |a Eighth Meeting in Geneva, Switzerland, from 12 to 19 October 2010 | ||
| 650 | 7 | |a Lepra |0 (DE-588)4035392-8 |2 gnd | |
| 650 | 7 | |a EPIDEMIOLOGIE + SEUCHEN (MEDIZIN) |x ger |0 (ETHUDK)000027020 |2 ethudk | |
| 650 | 7 | |a KONTROLLE VON INFEKTIONSKRANKHEITEN (ÖFFENTLICHES GESUNDHEITSWESEN) |x ger |0 (ETHUDK)000026495 |2 ethudk | |
| 650 | 7 | |a LEPRA (PATHOLOGIE) |x ger |0 (ETHUDK)000026950 |2 ethudk | |
| 650 | 7 | |a MYCOBACTERIUM LEPRAE (MIKROBIOLOGIE) |x ger |0 (ETHUDK)000023314 |2 ethudk | |
| 650 | 7 | |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |x ger |0 (ETHUDK)000026636 |2 ethudk | |
| 655 | 7 | |a Konferenzschrift |z Genf |y 2010 |2 gnd-content | |
| 691 | 7 | |B u |a LEPRA (PATHOLOGIE) |z ger |u 616-002.73 |2 nebis E1 | |
| 691 | 7 | |B u |a EPIDEMIOLOGIE + SEUCHEN (MEDIZIN) |z ger |u 616-036.22 |2 nebis E1 | |
| 691 | 7 | |B u |a MYCOBACTERIUM LEPRAE (MIKROBIOLOGIE) |z ger |u 579.8,112.501 |2 nebis E1 | |
| 691 | 7 | |B u |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |z ger |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a KONTROLLE VON INFEKTIONSKRANKHEITEN (ÖFFENTLICHES GESUNDHEITSWESEN) |z ger |u 614.4 |2 nebis E1 | |
| 691 | 7 | |B u |a LÈPRE (PATHOLOGIE) |z fre |u 616-002.73 |2 nebis E1 | |
| 691 | 7 | |B u |a LEPROSY (PATHOLOGY) |z eng |u 616-002.73 |2 nebis E1 | |
| 691 | 7 | |B u |a ÉPIDÉMIOLOGIE + ÉPIDÉMIES (MÉDECINE) |z fre |u 616-036.22 |2 nebis E1 | |
| 691 | 7 | |B u |a EPIDEMIOLOGY + EPIDEMICS + PLAGUES (MEDICINE) |z eng |u 616-036.22 |2 nebis E1 | |
| 691 | 7 | |B u |a MYCOBACTERIUM LEPRAE (MICROBIOLOGIE) |z fre |u 579.8,112.501 |2 nebis E1 | |
| 691 | 7 | |B u |a MYCOBACTERIUM LEPRAE (MICROBIOLOGY) |z eng |u 579.8,112.501 |2 nebis E1 | |
| 691 | 7 | |B u |a CLINICAL PHARMACOLOGY, THERAPEUTICAL PHARMACOLOGY, CHEMOTHERAPY, MEDICATION, ADMINISTRATION OF DRUGS |z eng |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMACOLOGIE THÉRAPEUTIQUE, APPLICATION DE MÉDICAMENTS, CHIMIOTHÉRAPIE, PHARMACOLOGIE CLINIQUE |z fre |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a CONTROL OF INFECTIOUS DISEASES (PUBLIC HEALTH) |z eng |u 614.4 |2 nebis E1 | |
| 691 | 7 | |B u |a CONTRÔLE DES MALADIES INFECTIEUSES (SANTÉ PUBLIQUE) |z fre |u 614.4 |2 nebis E1 | |
| 710 | 2 | |a Weltgesundheitsorganisation |b Expert Committee on Leprosy |0 (DE-588)127375-9 | |
| 773 | 0 | A | |t WHO expert committee on leprosy |g 8th report |j 8 |1 2012 |2 8 |w (IDSBB)006096138 |9 12235530X |
| 898 | |a BK020800 |b XK020000 |c XK020000 | ||
| 912 | 7 | |a 130 |2 E01 | |
| 949 | |B IDSBB |F A322 |b A322 |c 322AR |j TPH Zs WHO 3 : 968 |x akz:ba/psti/g/NELAA3221208 | ||
| 950 | |B IDSBB |P 490 |E 0- |a Technical report series / World Health Organization |v no. 968 |i 968 |w (IDSBB)005953281 |9 278782957 | ||
| 950 | |B IDSBB |P 710 |E 2- |a Weltgesundheitsorganisation |b Expert Committee on Leprosy |0 (DE-588)127375-9 | ||
| 950 | |B IDSBB |P 773 |E 0A |t WHO expert committee on leprosy |g 8th report |j 8 |1 2012 |2 8 |w (IDSBB)006096138 |9 12235530X | ||
| 950 | |B NEBIS |P 110 |E 2- |a Weltgesundheitsorganisation |b Expert Committee on Leprosy |0 (DE-588)127375-9 |e Verfasser |4 aut | ||
| 950 | |B NEBIS |P 490 |E 0- |a WHO technical report series |v 968 |i 968 |w (NEBIS)000023541 |9 278782957 | ||
| 956 | 4 | |B NEBIS |C EAD50 |u https://opac.nebis.ch/objects/pdf03/e16_978-92-4-120968-7_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |